Details for New Drug Application (NDA): 020980
✉ Email this page to a colleague
The generic ingredient in LAMISIL is terbinafine. There are twenty-seven drug master file entries for this compound. Additional details are available on the terbinafine profile page.
Summary for 020980
Tradename: | LAMISIL |
Applicant: | Karo Hlthcare |
Ingredient: | terbinafine hydrochloride |
Patents: | 0 |
Suppliers and Packaging for NDA: 020980
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LAMISIL | terbinafine hydrochloride | CREAM;TOPICAL | 020980 | NDA | Haleon US Holdings LLC | 0067-3998 | 0067-3998-30 | 1 TUBE in 1 CARTON (0067-3998-30) / 30 g in 1 TUBE |
LAMISIL | terbinafine hydrochloride | CREAM;TOPICAL | 020980 | NDA | Haleon US Holdings LLC | 0067-3998 | 0067-3998-42 | 1 TUBE in 1 CARTON (0067-3998-42) / 12 g in 1 TUBE |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | CREAM;TOPICAL | Strength | 1% | ||||
Approval Date: | Mar 9, 1999 | TE: | RLD: | Yes |
Expired US Patents for NDA 020980
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Karo Hlthcare | LAMISIL | terbinafine hydrochloride | CREAM;TOPICAL | 020980-001 | Mar 9, 1999 | 4,680,291 | ⤷ Subscribe |
Karo Hlthcare | LAMISIL | terbinafine hydrochloride | CREAM;TOPICAL | 020980-001 | Mar 9, 1999 | 4,755,534*PED | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription